Kronik Hastalıkların Tedavisinde Nutraceutical Nanoteknolojinin Terapötik Etkileri.
Therapeutic Implications of Nutraceutical Nanotechnology for the Treatment of Chronic Diseases.
DOI: 10.2174/0113892002415344251122122358PMID: 41510732
Therapeutic Implications of Nutraceutical Nanotechnology for the Treatment of Chronic Diseases.
DOI: 10.2174/0113892002415344251122122358PMID: 41510732
The use of fully immersive virtual reality for screening neurodegenerative diseases: A systematic review of behavioral and diagnostic outcomes.
DOI: 10.1002/dad2.70244PMID: 41522285
Striatal dopamine synthesis capacity in Parkinson's disease: Effects of age, sex, and body mass index in a large [<sup>18</sup>F]fluorodopa PET cohort.
DOI: 10.1016/j.nicl.2026.103944PMID: 41529450
Epigenetic Dysregulation in Neurodegeneration: The Role of Histone Deacetylases and Emerging Inhibitor Strategies.
DOI: 10.3390/biom16010103PMID: 41594643
Sexual Dysfunction in Individuals with Early-Onset Parkinson's Disease in Ethiopia: Gender Differences and Correlation with Anti-Parkinson's Medication, Stigma, and Distress.
DOI: 10.3390/healthcare14020153PMID: 41595289
Extended High-Frequency Hearing Thresholds and Categorical Loudness Scaling in Parkinson's Disease.
DOI: 10.1044/2025_jslhr-25-00151PMID: 41499653
Re-evaluating Dystonia-Linked Gene Variants in a Large European Parkinson's Disease Cohort.
DOI: 10.1002/mds.70173PMID: 41502184
Multimodal MRI data fusion reveals distinct structural, functional and neurochemical correlates of depression in patients with Parkinson's disease.
DOI: 10.1016/j.neuroimage.2026.121706PMID: 41512941
ALPS index and choroid plexus volume as indirect MRI biomarkers of glymphatic function for predicting cognitive decline in Parkinson's disease.
DOI: 10.1016/j.neuroimage.2026.121705PMID: 41512943
Neurological Adverse Effects of Antipsychotic Medication in Children and Young People.
DOI: 10.1007/s40272-025-00730-5PMID: 41498920
Neuroprotective effects of Bifidobacterium animalis HN019 and Lactobacillus acidophilus NCFM in MPTP-induced Parkinson's disease mice.
DOI: 10.1016/j.bbi.2026.106257PMID: 41513011
Retinal electrophysiological responses to dopaminergic therapy in treatment naïve Parkinson's disease.
DOI: 10.1007/s10633-025-10076-5PMID: 41495563
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.